401k Millionaire Count Dips as Workers Boost Savings to Record Levels Fidelity Q1 Data European Businesses Rely on China Manufacturing Amid EU DeRisking Efforts UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Industry Minister Huawei Unveils Advanced Chip Design Method Amid Intensifying AI Chip Rivalry with Nvidia and Apple ChatGPTs Bank Account Access Balancing Innovation with Privacy Risks Irans Potential Tariffs on Hormuz Internet Cables Could Raise Europes Connectivity Costs and Risks NVST Q1 2026 Earnings EPS Surpasses Expectations Stock Gains Organigram Global Inc OGI Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively Evaxion Q1 2026 Earnings EPS Widely Misses Estimates as ClinicalStage Biotech Continues Pipeline Investment SYBT Q1 2026 Earnings Small EPS Beat Meets Modest Market Reaction Delcath Systems Inc Q1 2026 Earnings Narrower Loss Surprises Markets TGT Q1 2026 Earnings EPS Surprises to the Upside Stock Reacts Positively BIPJ Shares Advance 120 as FixedIncome Demand Strengthens Virtus Equity Convertible Income Fund NIE Edges Lower Amidst Market Consolidation Graham Corporation GHM Holds Near Support as Slight Decline Tests Key Levels Saratoga Investment Corp 850 Notes due 2028 SAZ Slightly Lower Amid Steady FixedIncome Trading Oyster Enterprises II Acquisition Corp Rights OYSER Holds Steady at 014 Amid Low Activity Stock Market Futures Edge Higher as US Targets Iran Defense Stocks Like Elbit Systems in Focus The9 Limited NCTY Q1 2012 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid Revenue Uncertainty Orthofix Medical OFIX Drops 9 as Stock Tests Key Support Near 928 SIMO Q1 2026 Earnings Strong EPS Beat Drives Share Price Higher Epsilon Energy Ltd EPSN Q1 2026 Earnings Modest EPS Amid Low Volumes Stock Slightly Lower Atkore Inc ATKR Q1 2026 Earnings EPS Surges Past Expectations Shares Rally ALKS Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Disclosure Gap Stock Slips GMED Q1 2026 Earnings EPS Surges Past Estimates by 194 Stock Edges Lower DAIO Q1 2026 Earnings Loss Exceeds Estimates Stock Advances SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss